Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPY4R | P50391 | 9/20 | 0.38 |
| ▸ | NPY1R | P25929 | 6/20 | 0.38 |
| ▸ | DPP7 | Q9UHL4 | 2/20 | 0.38 |
| ▸ | OTC | P00480 | 1/20 | 0.37 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | NPY2R | P49146 | 4/20 | 0.35 |
| ▸ | NPY5R | Q15761 | 4/20 | 0.35 |
| ▸ | DDAH1 | O94760 | 1/20 | 0.35 |
| ▸ | GNAI3 | P08754 | 1/20 | 0.33 |
| ▸ | GNAO1 | P09471 | 1/20 | 0.33 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.33 |
| ▸ | NOS3 | P29474 | 1/20 | 0.33 |
| ▸ | NOS1 | P29475 | 1/20 | 0.33 |
| ▸ | NOS2 | P35228 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL288133 | 0.95 | NPY4R (0.39) | NPY4RNPY1RDPP7OTCALOX15 | |
| SCHEMBL9237239 | 0.95 | NPY4R (0.39) | NPY4RNPY1RDPP7OTCALOX15 | |
| SCHEMBL28712062 | 0.95 | NPY4R (0.39) | NPY4RNPY1RDPP7OTCALOX15 | |
| Hydrochloric Acid SCHEMBL8040222 | 0.93 | NPY4R (0.38) | NPY4RNPY1RDPP7OTCALOX15 | |
| SCHEMBL16194087 | 0.93 | NPY4R (0.38) | NPY4RNPY1RDPP7OTCALOX15 | |
| Hydrochloric Acid SCHEMBL8039440 | 0.93 | NPY4R (0.38) | NPY4RNPY1RDPP7OTCALOX15 | |
| SCHEMBL27606498 | 0.92 | NPY4R (0.38) | NPY4RNPY1RDPP7OTCALOX15 | |
| SCHEMBL15891 | 0.92 | NPY4R (0.38) | NPY4RNPY1RDPP7OTCALOX15 | |
| SCHEMBL27722340 | 0.90 | NPY4R (0.37) | NPY4RNPY1RDPP7OTCALOX15 | |
| SCHEMBL3406325 | 0.90 | NPY4R (0.37) | NPY4RNPY1RDPP7OTCALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 101 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3727600-B1 | AMINO ACID CARBAMATE COMPLEXES | COLGATE PALMOLIVE CO (US) | 2023-09-20 | — | — | EP | claimed |
| CN-111479614-B | Amino acid carbamate complexes | 高露洁-棕榄公司 | 2022-10-28 | — | — | CN | claimed |
| US-10857083-B2 | Amino acid carbamate complexes | COLGATE-PALMOLIVE COMPANY (US) | 2020-12-08 | — | — | US | claimed |
| EP-3727600-A1 | AMINO ACID CARBAMATE COMPLEXES | Colgate-Palmolive Company (US) | 2020-10-28 | — | — | EP | claimed |
| CN-111479614-A | Amino acid carbamate complexes | 高露洁-棕榄公司 | 2020-07-31 | — | — | CN | claimed |
| US-20190183765-A1 | Amino Acid Carbamate Complexes | COLGATE-PALMOLIVE COMPANY (US) | 2019-06-20 | — | — | US | claimed |
| US-20260130839-A1 | Oral Care Compositions | COLGATE-PALMOLIVE COMPANY (US) | 2026-05-14 | — | — | US | disclosed |
| US-20260090966-A1 | UROLITHIN COMPOSITIONS | AMAZENTIS SA (CH) | 2026-04-02 | — | — | US | disclosed |
| US-12521336-B2 | Oral care compositions | COLGATE-PALMOLIVE COMPANY (US) | 2026-01-13 | — | — | US | disclosed |
| WO-2025245012-A1 | METHODS FOR MANUFACTURING A TOOTHPASTE COMPOSITION | COLGATE-PALMOLIVE COMPANY (US) | 2025-11-27 | — | — | WO | disclosed |
| US-20250352439-A1 | ORAL COMPOSITIONS | COLGATE-PALMOLIVE COMPANY (US) | 2025-11-20 | — | — | US | disclosed |
| EP-4167941-B1 | ORAL CARE COMPOSITIONS CONTAINING SODIUM LAUROYL SARCOSINATE AND BETAINE | COLGATE PALMOLIVE CO (US) | 2025-10-15 | — | — | EP | disclosed |
| US-20250295564-A1 | Oral Care Whitening Compositions | COLGATE-PALMOLIVE COMPANY (US) | 2025-09-25 | — | — | US | disclosed |
| WO-2021041515-A1 | ORAL CARE COMPOSITIONS HAVING INCREASED FOAM PRODUCTION AND METHODS FOR THE SAME | COLGATE-PALMOLIVE COMPANY (US) | 2021-03-04 | — | — | WO | disclosed |
| US-20210059918-A1 | Oral Care Compositions Having Increased Foam Production and Methods for the Same | COLGATE-PALMOLIVE COMPANY (US) | 2021-03-04 | — | — | US | disclosed |
| US-10857083-B2 | Amino acid carbamate complexes | COLGATE-PALMOLIVE COMPANY (US) | 2020-12-08 | — | — | US | disclosed |
| EP-3727600-A1 | AMINO ACID CARBAMATE COMPLEXES | Colgate-Palmolive Company (US) | 2020-10-28 | — | — | EP | disclosed |
| CN-111479614-A | Amino acid carbamate complexes | 高露洁-棕榄公司 | 2020-07-31 | — | — | CN | disclosed |
| US-20190183765-A1 | Amino Acid Carbamate Complexes | COLGATE-PALMOLIVE COMPANY (US) | 2019-06-20 | — | — | US | disclosed |
| US-20040092592-A1 | Stabilized L-Arginine platelet aggregation inhibitory compositions and processes for making same | KAPLAN LEONARD L (US) | 2004-05-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260090966-A1 | UROLITHIN COMPOSITIONS | UTS2R, TAS2R30, TAS2R42 | NPY4R 3509/4885NPY1R 2221/4885DPP7 2081/4885 |
| US-10857083-B2 | Amino acid carbamate complexes | CPS1, GLUL, PROC | NPY4R 4375/4885NPY1R 4225/4885DPP7 240/4885 |
| US-20260130839-A1 | Oral Care Compositions | FLNA, CHD9, CARHSP1 | NPY4R 3782/4885NPY1R 2930/4885DPP7 1962/4885 |
| US-20210059918-A1 | Oral Care Compositions Having Increased Foam Production and Methods for the Same | FHIT, DDOST, FGB | NPY4R 4758/4885NPY1R 4619/4885DPP7 3618/4885 |
| US-20190183765-A1 | Amino Acid Carbamate Complexes | CPS1, GLUL, PROC | NPY4R 4375/4885NPY1R 4225/4885DPP7 240/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.